SNN News and Press, Smith & Nephew SNATS Inc. From 03/08/23

Smith+Nephew to highlight procedural innovations in Sports Medicine during AAOS 2023 Annual Meeting PR Newswire LONDON , March 8, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN) (NYSE:SNN), the global medical technology company, today announces it will showcase its la...

Smith+Nephew unveils 'Precision in Motion' for its Orthopaedics Arthroplasty portfolio at AAOS 2023 Annual Meeting PR Newswire An uncompromising commitment to freedom of movement LONDON , March 7, 2023 /PRNewswire/ -- Smith+Nephew (LSE: SN, NYSE: SNN), th...

Smith+Nephew Sports Medicine advances procedural innovation by launching the QUADTRAC™ Quadriceps Tendon Harvest Guide System and expanded family of ULTRABUTTON™ Adjustable Fixation Devices for ACL reconstruction PR Newswire LONDON , March 7, 2023 /...

Smith+Nephew's VISIONAIRE™ Patient-Specific Instrumentation shown to improve outcome measures for total knee arthroplasty compared with conventional instrumentation PR Newswire LONDON , March 6, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), th...

Summary Enovis came up a little short with revenue and margins for both the fourth quarter of 2022 and guidance for 2023. The Reconstructive segment is performing well, with growth in U.S. hips, knees, and extremities that was well ahead of the group. The Prevention & Recovery b...

Summary Smith & Nephew saw flat top-line growth, declines in earnings and CFFO relative to FY21. Management has instilled a new 12-point plan in order to drive performance from FY23 onwards. It is now a matter of execution, and we rate SNN a hold at 24x earnings, in-line with th...

Summary Company reports top-line growth in Q4. Innovation & operational leverage finally turning the screw here. Shares remain cheap. We see higher prices coming for the stock in 2023. Intro We wrote about Smith & Nephew plc ( SNN ) in July of last ...

Summary Smith & Nephew plc's fourth quarter results were mixed; Ortho is still lagging its rivals, but Sports Medicine & ENT and Advanced Wound Care outperformed. The company has the technology to be more competitive in ortho and gain share in major joints and extremities, but w...

Smith & Nephew plc (SNN) Q4 2022 Earnings Conference Call February 21, 2023, 03:30 AM ET Company Participants Deepak Nath - CEO Anne-Francoise Nesmes - CFO Conference Call Participants Jack Reynolds-Clark - RBC Hassan Al-Wakeel - Barclays Kyle Rose ...

Smith & Nephew ( NYSE: SNN ) stock rose ~6% on Tuesday after Q4 revenue grew and the company provided FY23 outlook. Q4 revenue grew 1.4% Y/Y to ~$1.37B. Revenue from Orthopaedics segment fell -0.4% Y/Y to $549M, while revenue from Sports Medicine & ENT grew +...